Dehydration Clinical Trial
Official title:
Spectrophon Dehydration Body Monitor Accuracy Evaluation
Monitoring of a person's physical status is a key point for maintaining of "healthy life". Wearable devices provide a unique possibility for real-time monitoring. This study aims to estimate the accuracy of Spectrophon Dehydration Body Monitor (DBM) incorporated in smartwatch Samsung Gear S2 and sport band Samsung Gear Fit2 by comparing data obtained by DBM with the total weight lost during exertion.
Reduced physical activity is considered as a risk factor for obesity, diabetes, cancer and
depression. A proper exercise program can mitigate cognitive and physical decline associated
with ageing. Existing general guidelines for physical activity are not universal or
appropriate for every person. A personalized approach based on a subject age and unique
combination of different physiological parameters would serve as a solution for finding
optimal training protocols for individuals. Hence, monitoring basic physiological and
biochemical parameters and obtaining information reflecting the body metabolic state is
necessary for health status estimation to develop the abovementioned personally-oriented
training protocols. Dehydration Body Monitor (DBM) developed by Spectrophon L.T.D. can
measure sweat lost, salt concentration in sweat, and sweating dynamics, which can be used for
personal physical status monitoring. This is important not only for controlling appropriate
body hydration level but also for keeping kidneys "healthy". Currently, only few DBM tools
are available on the market, so there is a growing need for new effective accurate real-time
DBM sensors.
The main objective of current study is to estimate the accuracy of Spectrophon DBM
incorporated in smartwatch Samsung Gear S2 and sport band Samsung Gear Fit2. The secondary
aim of the study is to evaluate the safety-in-use of Spectrophon DBM.
Tested device:
Name: Dehydration Body Monitor; Source: Spectrophon, L.T.D.; Model: SP-DBM Firmware version:
1.5
4. Experimental Design Healthy adults (n=200) in different age and gender groups were
recruited for the study. Samsung Gear S2 smartwatch with Spectrophon DBM attached to the
bottom of the smartwatch were placed on the right wrist of each participant. At the same
time, Samsung Gear Fit2 sport band with Spectrophon DBM attached to the bottom of the band
was placed on the left wrist of the participant. Each participant was subjected to moderate
physical activity. Data from Samsung Gear S2 and Samsung Gear Fit2 was obtained
simultaneously. In parallel, subject weight was also monitored using commercially available
digital balancers (Shekel B-200-P).
The evaluation of the measurement accuracy of the Spectrophon DBM was defined as the
difference between subject weight change during the exertion (due to sweating and water
consumption) and the volume of sweat detected by Spectrophon DBM.
5. Procedures: Participants were weighed prior to the experiment (no clothing after maximal
drying) and then subjected to physical activity (walking on the treadmill).
Total duration of study: 90 minutes
5.2 Intensity of exercises:
Participants could choose high or low intensity of exertion:
1. High: up to 6.5km/h;
2. Low: yo to 6.0km/h; 5.3 Data recording: After DBM application was activated, DBM started
recording data (sweat rate and total salt in sweat) every 20 sec. and automatically
saved results into archive on a mobile phone linked to Samsung Gear S2 or Samsung Gear
Fit2 by Bluetooth. Manual recording of data was conducted during breaks Participants
were also weighed during each break (no clothing after maximal drying).
5.4. Drinking During the procedure, subjects could drink up to 500 ml of water. The weight of
the bottle was measured and recorded after drinking during breaks. The difference was
subtracted to the weight loss calculation.
5.5 Restrictions:
In this experiment, the following was avoided:
1. Urination during test (empty before T0)
2. Weight loss should not exceed 2%
Participants could cancel the experiment at any point of the procedure if desired.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04079543 -
NPO and Patient Satisfaction in the Cath Lab
|
N/A | |
Recruiting |
NCT06063655 -
Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults
|
N/A | |
Completed |
NCT05111392 -
Hydration Dynamics and Influence of Beverage Composition
|
Phase 1/Phase 2 | |
Terminated |
NCT02486224 -
Metabolomic Analysis of the Impacts of Hydration Status on Exercise Performance
|
N/A | |
Recruiting |
NCT02249845 -
Comparing the Diagnostic Accuracy of Clinical Dehydration Scales Among Small Children
|
N/A | |
Completed |
NCT01285713 -
IV Glucose for Dehydration Treatment
|
Phase 2 | |
Withdrawn |
NCT00691275 -
Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration
|
N/A | |
Completed |
NCT00360204 -
Improving Health Outcomes for New Mothers and Babies
|
Phase 3 | |
Completed |
NCT00370968 -
Zinc-ORS in Severe and Complicated Acute Diarrhea
|
Phase 2/Phase 3 | |
Completed |
NCT04076995 -
INDIGO-2: The Effect of High Water Intake on Glucose Regulation in Low-drinkers
|
N/A | |
Recruiting |
NCT05768789 -
Buoy Electrolyte Study on Hydration Status of Active Men and Women
|
N/A | |
Not yet recruiting |
NCT05428228 -
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
|
N/A | |
Completed |
NCT04997031 -
Tap Water Intake and Perceptions in US Latinx Adults
|
||
Completed |
NCT04536324 -
The Absorption Rate of Subcutaneous Infused Fluid
|
||
Completed |
NCT02926989 -
Intravenous Fluids in Hospitalised Children
|
Phase 4 | |
Completed |
NCT04874584 -
Culturally Tailored Nurse Coaching Study for Cancer Symptom Management
|
N/A | |
Completed |
NCT02206581 -
Using Hydration Monitor to Detect Changes in the Hydration Status Athletes
|
N/A | |
Completed |
NCT02265575 -
Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration
|
Phase 2 | |
Completed |
NCT01893853 -
Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study)
|
N/A | |
Completed |
NCT01503996 -
Drinking Habits of Glaucoma Patients and Age Matched Controls
|
N/A |